Revenue -- Reported at approximately EUR 266 million, reflecting a 7% decline year over year. Ex-TAC gross profit -- Stated as EUR 108 million, growing 5% year over year, with pro forma decline of 11% ...
MarketBeat on MSN
BioAge Labs R&D Day: BGE-102 phase I shows big hs-CRP drops, sets up cardio & DME POC trials
BioAge Labs (NASDAQ:BIOA) used its R&D Day event to provide an update on its lead program, BGE-102, an oral, brain-penetrant ...
This trend is especially evident in the segment of ice hockey betting online, where data accuracy directly affects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results